Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,070 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Metformin use and lung cancer survival: a population-based study in Norway.
Brancher S, Støer NC, Weiderpass E, Damhuis RAM, Johannesen TB, Botteri E, Strand TE. Brancher S, et al. Among authors: weiderpass e. Br J Cancer. 2021 Mar;124(5):1018-1025. doi: 10.1038/s41416-020-01186-9. Epub 2020 Dec 2. Br J Cancer. 2021. PMID: 33262518 Free PMC article.
Associations between ocular melanoma and other primary cancers: an international population-based study.
Scélo G, Boffetta P, Autier P, Hemminki K, Pukkala E, Olsen JH, Weiderpass E, Tracey E, Brewster DH, McBride ML, Kliewer EV, Tonita JM, Pompe-Kirn V, Chia KS, Jonasson JG, Martos C, Giblin M, Brennan P. Scélo G, et al. Among authors: weiderpass e. Int J Cancer. 2007 Jan 1;120(1):152-9. doi: 10.1002/ijc.22159. Int J Cancer. 2007. PMID: 17036322 Free article.
Risk of second primary cancer among esophageal cancer patients: a pooled analysis of 13 cancer registries.
Chuang SC, Hashibe M, Scelo G, Brewster DH, Pukkala E, Friis S, Tracey E, Weiderpass E, Hemminki K, Tamaro S, Chia KS, Pompe-Kirn V, Kliewer EV, Tonita JM, Martos C, Jonasson JG, Dresler CM, Boffetta P, Brennan P. Chuang SC, et al. Among authors: weiderpass e. Cancer Epidemiol Biomarkers Prev. 2008 Jun;17(6):1543-9. doi: 10.1158/1055-9965.EPI-07-2876. Cancer Epidemiol Biomarkers Prev. 2008. PMID: 18559572
Risk of second primary cancer among patients with head and neck cancers: A pooled analysis of 13 cancer registries.
Chuang SC, Scelo G, Tonita JM, Tamaro S, Jonasson JG, Kliewer EV, Hemminki K, Weiderpass E, Pukkala E, Tracey E, Friis S, Pompe-Kirn V, Brewster DH, Martos C, Chia KS, Boffetta P, Brennan P, Hashibe M. Chuang SC, et al. Among authors: weiderpass e. Int J Cancer. 2008 Nov 15;123(10):2390-6. doi: 10.1002/ijc.23798. Int J Cancer. 2008. PMID: 18729183 Free article.
Risks of second primary cancer among patients with major histological types of lung cancers in both men and women.
Chuang SC, Scélo G, Lee YC, Friis S, Pukkala E, Brewster DH, Hemminki K, Tracey E, Weiderpass E, Tamaro S, Pompe-Kirn V, Kliewer EV, Chia KS, Tonita JM, Martos C, Jonasson JG, Boffetta P, Brennan P, Hashibe M. Chuang SC, et al. Among authors: weiderpass e. Br J Cancer. 2010 Mar 30;102(7):1190-5. doi: 10.1038/sj.bjc.6605616. Br J Cancer. 2010. PMID: 20354532 Free PMC article.
Dietary flavonoid, lignan and antioxidant capacity and risk of hepatocellular carcinoma in the European prospective investigation into cancer and nutrition study.
Zamora-Ros R, Fedirko V, Trichopoulou A, González CA, Bamia C, Trepo E, Nöthlings U, Duarte-Salles T, Serafini M, Bredsdorff L, Overvad K, Tjønneland A, Halkjaer J, Fagherazzi G, Perquier F, Boutron-Ruault MC, Katzke V, Lukanova A, Floegel A, Boeing H, Lagiou P, Trichopoulos D, Saieva C, Agnoli C, Mattiello A, Tumino R, Sacerdote C, Bueno-de-Mesquita HB, Peeters PH, Weiderpass E, Engeset D, Skeie G, Argüelles MV, Molina-Montes E, Dorronsoro M, Tormo MJ, Ardanaz E, Ericson U, Sonestedt E, Sund M, Landberg R, Khaw KT, Wareham NJ, Crowe FL, Riboli E, Jenab M. Zamora-Ros R, et al. Among authors: weiderpass e. Int J Cancer. 2013 Nov 15;133(10):2429-43. doi: 10.1002/ijc.28257. Epub 2013 Jun 4. Int J Cancer. 2013. PMID: 23649669 Free article.
Coffee and tea consumption, genotype-based CYP1A2 and NAT2 activity and colorectal cancer risk-results from the EPIC cohort study.
Dik VK, Bueno-de-Mesquita HB, Van Oijen MG, Siersema PD, Uiterwaal CS, Van Gils CH, Van Duijnhoven FJ, Cauchi S, Yengo L, Froguel P, Overvad K, Bech BH, Tjønneland A, Olsen A, Boutron-Ruault MC, Racine A, Fagherazzi G, Kühn T, Campa D, Boeing H, Aleksandrova K, Trichopoulou A, Peppa E, Oikonomou E, Palli D, Grioni S, Vineis P, Tumino R, Panico S, Peeters PH, Weiderpass E, Engeset D, Braaten T, Dorronsoro M, Chirlaque MD, Sánchez MJ, Barricarte A, Zamora-Ros R, Argüelles M, Jirström K, Wallström P, Nilsson LM, Ljuslinder I, Travis RC, Khaw KT, Wareham N, Freisling H, Licaj I, Jenab M, Gunter MJ, Murphy N, Romaguera-Bosch D, Riboli E. Dik VK, et al. Among authors: weiderpass e. Int J Cancer. 2014 Jul 15;135(2):401-12. doi: 10.1002/ijc.28655. Epub 2013 Dec 21. Int J Cancer. 2014. PMID: 24318358 Free article.
1,070 results